Prostate cancer antigen-1 as a potential novel marker for prostate cancer

Asian Journal of Andrology

Volumn 9, Issue 6, 2007, Pages 821-826

  Liu, Bing Qian ^a   Wu, Yu Dong ^a   Li, Pei Huan ^b   Wei, Jin Xing ^a   Zhang, Tong ^c   Liu, Ran Lu ^d  

^a ZHENGZHOU UNIVERSITY   (China)

^b INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^d TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Marker; Prostate cancer; Prostate cancer antigen 1

Indexed keywords

MESSENGER RNA; PROSTATE CANCER ANTIGEN 1; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; GENE EXPRESSION; GLEASON SCORE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

AGED; ANTIGENS, NEOPLASM; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DNA, COMPLEMENTARY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 36048951731     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1111/j.1745-7262.2007.00279.x     Document Type: Article

References (13)

1. Kumar-Sinha C, Chinnaiyan AM. Molecular markers to identify patients at risk for recurrence after primary treatment for prostate cancer. J Urol 2003; 62: 19-35.
2. Gray JM. Population screening and patient testing using PSA. BJU Int 2005; 95: 3.
3. Hara N, Kitamura Y, Saito T, Komatsubara S. Total and free prostate-specific antigen indexes in prostate cancer screening: Value and limitation for Japanese populations. Asian J Androl 2006; 8: 429-34.
4. Li XM, Zhang L, Li J, Li Y, Wang HL, Ji GY, et al. Measurement of serum zinc improves prostate cancer detection efficiency in patients with PSA levels between 4 ng/mL and 10 ng/mL. Asian J Androl 2005; 7: 323-8.
5. Konishi N, Nakamura M, Ishida E, Shimada K, Mitsui E, Yoshikawa R, et al. High expression of a new marker PCA-1 in human prostate carcinoma. Clin Cancer Res 2005; 11: 5090-7.
6. Zhao ZG, Shen WL. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer. World J Surg Oncol 2004; 2: 13-20.
7. Mishina Y, Duguid EM, He C. Direct reversal of DNA alkylation damage. Chem Rev 2006; 106: 215-32.
8. Sedgwick B, Lindahl T. Recent progress on the Ada response for inducible repair of DNA alkylation damage. Oncogene 2002; 21: 8886-94.
9. Dinglay S, Trewick SC, Lindahl T, Sedgwick B. Defective processing of methylated single-stranded DNA by E. coli AlkB mutants. Genes Dev 2000; 14: 2097-105.
10. Aas PA, Otterlei M, Falnes PO, Vagbo GB, Skorpen F, Akbari M, et al. Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature 2003; 421: 859-63.
11. Sofikerim M, Tatlisen A, Karacagil M. Do all patients with high-grade prostatic intraepithelial neoplasia on initial prostatic biopsy eventually progress to clinical prostate cancer? BJU Int 2006: 97; 869-70.
12. Dakubo GD, Parr RL, Costello LC, Franklin RB, Thayer RE. Altered metabolism and mitochondrial genome in prostate cancer. J Clin Pathol 2006; 59: 10-6.
13. Konishi N, Nakamura M, Kishi M, Nishimine M, Ishida E, Shimada K. Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomas. Am J Pathol 2002; 160: 1207-14.